Skip to main content
Log in

Rotavirus, Hib, PCV immunisation large economic benefits in India

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Constenla D, et al. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses. Vaccine : 10 Oct 2019. Available from: URL: http://doi.org/10.1016/j.vaccine.2019.09.084

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rotavirus, Hib, PCV immunisation large economic benefits in India. PharmacoEcon Outcomes News 840, 25 (2019). https://doi.org/10.1007/s40274-019-6342-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6342-3

Navigation